SCHEMBL14702952

SCHEMBL14702952

Oc1c(Cl)cc(Cl)cc1CSC1CCCCCC[C@@H]1SCc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.50
▸ CYP2C9 P11712 4/20 0.50
▸ PRMT1 Q99873 1/20 0.49
▸ HSP90AA1 P07900 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.39
▸ CYP3A4 P08684 4/20 0.39
▸ TSHR P16473 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ RECQL P46063 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ LMNA P02545 4/20 0.38
▸ HTT P42858 3/20 0.38
▸ MEN1 O00255 6/20 0.37
▸ KMT2A Q03164 6/20 0.37
▸ HPGD P15428 5/20 0.37
▸ MAPT P10636 4/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ ALOX12 P18054 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16077847 1.00 CYP1A2 (0.50) CYP1A2CYP2C9PRMT1HSP90AA1ALDH1A1
SCHEMBL14682856 1.00 CYP1A2 (0.50) CYP1A2CYP2C9PRMT1HSP90AA1ALDH1A1
SCHEMBL15781538 0.81 CYP2D6 (0.44) CYP1A2CYP2C9PRMT1ALDH1A1CYP3A4
SCHEMBL10356919 0.76 HSP90AA1 (0.44) CYP1A2CYP2C9PRMT1HSP90AA1ALDH1A1
SCHEMBL14682857 0.72 CYP1A2 (0.40) CYP1A2CYP2C9ALDH1A1TSHRHSD17B10
SCHEMBL16077844 0.72 TTR (0.39) CYP2C9CYP2C19HIF1ATTR
SCHEMBL14702951 0.72 CYP2D6 (0.56) CYP1A2CYP2C9ALDH1A1CYP3A4TSHR
SCHEMBL14682853 0.72 TTR (0.39) CYP2C9CYP2C19HIF1ATTR
SCHEMBL14749262 0.72 CYP1A2 (0.40) CYP1A2CYP2C9ALDH1A1TSHRHSD17B10
SCHEMBL14682861 0.72 CYP2D6 (0.56) CYP1A2CYP2C9ALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695260-B2 Method for producing olefin block polymer using plurality of types of transition metal catalysts SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-04 — — US disclosed
US-20130059991-A1 CATALYST FOR STEREOSELECTIVE OLEFIN POLYMERIZATION AND METHOD FOR MANUFACTURING STEREOSELECTIVE POLYOLEFIN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-03-07 — — US disclosed
US-20130041119-A1 OLEFIN POLYMER PRODUCING METHOD, ETHYLENE POLYMER, AND MOLD PRODUCT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059991-A1 CATALYST FOR STEREOSELECTIVE OLEFIN POLYMERIZATION AND METHOD FOR MANUFACTURING STEREOSELECTIVE POLYOLEFIN OR10J3, ORMDL3, OGFRL1 CYP1A2 1668/4885CYP2C9 1731/4885PRMT1 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback